BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7346674)

  • 1. [Serologic analysis of tumor antibodies in the sera of patients with carcinoma of the larynx (author's transl)].
    Blume N; Milatovic D
    Laryngol Rhinol Otol (Stuttg); 1981 Aug; 60(8):405-6. PubMed ID: 7346674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tumor associated antigens induce humoral and cellular immune response to laryngeal carcinomas (author's transl)].
    Zenner HP; Herrmann IF
    Laryngol Rhinol Otol (Stuttg); 1979 Nov; 58(11):865-70. PubMed ID: 529958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic epitopes of three tumor-associated antigens of well-differentiated squamous cell carcinoma of the larynx for use in monitoring patients in specific active immunochemotherapy trials.
    Hollinshead AC
    Cancer Detect Prev; 1987; 10(3-4):153-8. PubMed ID: 2436778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Squamous cell carcinoma antigen levels in patients with laryngeal cancer].
    Polberg K; Stepulak A; Stryjecka-Zimmer M; Kupisz K; Zawiślak J
    Pol Merkur Lekarski; 2005 Sep; 19(111):375-6. PubMed ID: 16358876
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Antibodies against tumor associated antigens of human bronchogenic carcinoma: demonstration by anti-complement immunofluorescence (author's transl)].
    Schlipköter HW; Stiller-Winkler R; Idel H; Knopp J
    Zentralbl Bakteriol Mikrobiol Hyg B; 1981; 174(1-2):105-14. PubMed ID: 7034407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunglobulins in serum of laryngeal and pharyngeal cancer patients (author's transl)].
    Niksić M; Balogh M
    Laryngol Rhinol Otol (Stuttg); 1976 Nov; 55(11):882-7. PubMed ID: 136570
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Determination of the relative affinities of antibody fragments expressed in Escherichia coli by enzyme-linked immunosorbent assay.
    Watkins JD; Beuerlein G; Pecht G; McFadden PR; Glaser SM; Huse WD
    Anal Biochem; 1997 Nov; 253(1):37-45. PubMed ID: 9356139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human tumor cell lysates as a protein source for the detection of cancer antigen-specific humoral immunity.
    Goodell V; Disis ML
    J Immunol Methods; 2005 Apr; 299(1-2):129-38. PubMed ID: 15914197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A quantitative nitrocellulose enzyme immunoassay and its application to the screening of hybridomas for the detection of uncharacterized tumor-associated antigens in sera of cancer patients.
    Liu YS; Daniels JK; Nelson PA
    J Immunoassay; 1988; 9(3-4):335-48. PubMed ID: 3235688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression and immunogenicity of a tumor-associated antigen, 90K/Mac-2 binding protein, in lung carcinoma.
    Ozaki Y; Kontani K; Hanaoka J; Chano T; Teramoto K; Tezuka N; Sawai S; Fujino S; Yoshiki T; Okabe H; Ohkubo I
    Cancer; 2002 Nov; 95(9):1954-62. PubMed ID: 12404290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Detection of antitumor-antibodies in patients with tonsillar carcinoma (author's transl)].
    Mang WL; Hammer C; Gruber F; Weinfurtner F; Allmeling A; Brendel W
    Laryngol Rhinol Otol (Stuttg); 1981 Jan; 60(1):11-5. PubMed ID: 7012490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ovarian cancer: immunologic diagnosis and therapy.
    Barber HR; Dorsett B
    Contrib Gynecol Obstet; 1985; 14():176-84. PubMed ID: 3905251
    [No Abstract]   [Full Text] [Related]  

  • 13. [Production and preclinical use of a monoclonal immunotoxin against laryngeal cancer cells].
    Zenner HP
    Laryngol Rhinol Otol (Stuttg); 1984 Nov; 63(11):566-9. PubMed ID: 6521585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serological identification of tumor antigens of esophageal squamous cell carcinoma.
    Shimada H; Nakashima K; Ochiai T; Nabeya Y; Takiguchi M; Nomura F; Hiwasa T
    Int J Oncol; 2005 Jan; 26(1):77-86. PubMed ID: 15586227
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of HCC-22-5 tumor-associated antigen and antibody response in patients.
    Zhou SF; Xie XX; Bin YH; Lan L; Chen F; Luo GR
    Clin Chim Acta; 2006 Apr; 366(1-2):274-80. PubMed ID: 16356486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Antigen mimicry of anti-idiotypic antibodies for human ovarian carcinoma antigen: generation and characterization of anti anti-idiotype antibodies].
    Lu WY; Qian HN
    Zhonghua Yi Xue Za Zhi; 1993 Oct; 73(10):581-3, 636. PubMed ID: 7508814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoimmune response to anti-apoptotic protein survivin and its association with antibodies to p53 and c-myc in cancer detection.
    Megliorino R; Shi FD; Peng XX; Wang X; Chan EK; Tan EM; Zhang JY
    Cancer Detect Prev; 2005; 29(3):241-8. PubMed ID: 15896923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of a cell line (T201) derived from a human larynx squamous cell carcinoma.
    Croce MV; Colussi AG; Zambelli A; Price MR; Segal-Eiras A
    Int J Oncol; 2001 Apr; 18(4):729-35. PubMed ID: 11251167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prognostic value of immunofluorescence from oral swabs in patients with tonsillar carcinoma.
    Mang WL; Hammer C
    J Med; 1981; 12(6):447-53. PubMed ID: 7033427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The cancer recognition (CARE) antibody test.
    Thornthwaite JT; McDuffee EC; Harris RB; Secor McVoy JR; Lane IW
    Cancer Lett; 2004 Dec; 216(2):227-41. PubMed ID: 15533599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.